According to Zacks, “P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. “
Separately, William Blair assumed coverage on P3 Health Partners in a research note on Tuesday, January 4th. They issued an outperform rating for the company.
In related news, major shareholder Michael Balkin purchased 15,000 shares of the company’s stock in a transaction on Friday, January 28th. The stock was bought at an average price of $4.83 per share, with a total value of $72,450.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
A number of institutional investors have recently added to or reduced their stakes in PIII. Granite Point Capital Management L.P. purchased a new position in P3 Health Partners during the fourth quarter worth $1,126,000. Emfo LLC purchased a new stake in shares of P3 Health Partners in the fourth quarter valued at $2,194,000. Sanders Morris Harris LLC purchased a new stake in shares of P3 Health Partners in the fourth quarter valued at $787,000. Geode Capital Management LLC purchased a new stake in shares of P3 Health Partners in the fourth quarter valued at $319,000. Finally, Blair William & Co. IL purchased a new stake in shares of P3 Health Partners in the fourth quarter valued at $204,000.
About P3 Health Partners (Get Rating)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
- Get a free copy of the StockNews.com research report on P3 Health Partners (PIII)
- OrganiGram’s Turnaround Begins To Blossom
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Greenbrier Companies Stock has Green in its Future
- Insiders Are Selling Palo Alto Networks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.